Impact of Peripheral α7-Nicotinic Acetylcholine Receptors on Cardioprotective Effects of Donepezil in Chronic Heart Failure Rats Meihua LiCan ZhengMasaru Sugimachi Original Article 29 August 2020 Pages: 877 - 888
Rhodiola crenulata reduces ventricular arrhythmia through mitigating the activation of IL-17 and inhibiting the MAPK signaling pathway Ya-Wen HsiaoYung-Nan TsaiShih-Ann Chen Original Article 18 September 2020 Pages: 889 - 900
Extracellular Vesicles Derived from Intermittent Hypoxia–Treated Red Blood Cells Impair Endothelial Function Through Regulating eNOS Phosphorylation and ET-1 Expression Lu PengYu LiHuina Zhang Original Article 26 November 2020 Pages: 901 - 913
Methotrexate Therapy Promotes Cell Coverage and Stability in in-Stent Neointima Xianglan LiuRuoxi ZhangBo Yu Original Article 04 January 2021 Pages: 915 - 925
Prolonged-release pirfenidone prevents obesity-induced cardiac steatosis and fibrosis in a mouse NASH model Jorge Gutiérrez-CuevasAna Sandoval-RodríguezJuan Armendáriz-Borunda Original Article 03 July 2020 Pages: 927 - 938
Suppression of Vascular Macrophage Activation by Nitro-Oleic Acid and its Implication for Abdominal Aortic Aneurysm Therapy Yang ZhaoZiyi ChangY. Eugene Chen Original Article 15 July 2020 Pages: 939 - 951
Factor Xa Inhibition with Apixaban Does Not Influence Cardiac Remodelling in Rats with Heart Failure After Myocardial Infarction Salva R. YuristaHerman H. W. SilljéB. Daan Westenbrink Original Article Open access 26 May 2020 Pages: 953 - 963
Patient Characteristics and Treatment Patterns among Medicare Beneficiaries Initiating PCSK9 Inhibitor Therapy Xue FengFlora BerkleinPei-Jung Lin Original Article 27 June 2020 Pages: 965 - 973
Effectiveness and Safety of Direct Oral Anticoagulants in an Asian Population with Atrial Fibrillation Undergoing Dialysis: A Population-Based Cohort Study and Meta-Analysis Lai-Chu SeeHsin-Fu LeeGregory Y. H. Lip Original Article 19 November 2020 Pages: 975 - 986
Comparison of antithrombotic strategies in patients with cryptogenic stroke and patent foramen ovale: an updated meta-analysis Filippo AngeliniFederico FortuniMaurizio Paciaroni Original Article 12 September 2020 Pages: 987 - 993
Comparing anticoagulation therapy alone versus anticoagulation plus single antiplatelet drug therapy after transcatheter aortic valve implantation in patients with an indication for anticoagulation: a systematic review and meta-analysis Yong ZhuShuai MengZening Jin Original Article 08 October 2020 Pages: 995 - 1002
Direct Current Cardioversion in Atrial Fibrillation Patients on Edoxaban Therapy Versus Vitamin K Antagonists: a Real-world Propensity Score–Matched Study Anna RagoAndrea Antonio PapaVincenzo Russo Original Article Open access 18 September 2020 Pages: 1003 - 1007
Strategies to Reduce Out-of-Pocket Medication Costs for Canadians Living with Heart Failure William F. McIntyrePeter BelesiotisEmilie P. Belley-Côté Original Article 17 August 2020 Pages: 1009 - 1023
Epigenetic Regulation of Endothelial Cell Function by Nucleic Acid Methylation in Cardiac Homeostasis and Disease Adam Russell-HallinanChris J. WatsonKarla M. O’Neill Review Article Open access 04 August 2020 Pages: 1025 - 1044
Ivabradine in Cardiovascular Disease Management Revisited: a Review Christopher ChenGurleen KaurMandeep S. Sidhu Review Article 07 January 2021 Pages: 1045 - 1056
Effects and Safety of a Novel Oral Potassium-Lowering Drug-Sodium Zirconium Cyclosilicate for the Treatment of Hyperkalemia: a Systematic Review and Meta-Analysis Yaru ZhangRuiling XuShan Lin Review Article Open access 18 January 2021 Pages: 1057 - 1066
Relative Efficacy of Sacubitril-Valsartan, Vericiguat, and SGLT2 Inhibitors in Heart Failure with Reduced Ejection Fraction: a Systematic Review and Network Meta-Analysis Alberto AimoKonstantinos PaterasGeorgios Georgiopoulos Review Article 19 October 2020 Pages: 1067 - 1076
Sotagliflozin Reduces HF Events in T2DM Regardless of Baseline Characteristics, Including HF, CKD and LVEF Li-Min ZhaoLiang-Liang DingMei Qiu Letter to the Editor 28 June 2021 Pages: 1077 - 1078
Dose-Dependent Risk Reduction for Myocardial Infarction with Eicosapentaenoic Acid: a Meta-analysis and Meta-regression Including the STRENGTH Trial Philip SarajlicGonzalo ArtiachMagnus Bäck Letter to the Editor Open access 08 June 2021 Pages: 1079 - 1081
